CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard Walls, Alastair Greystoke, Anthony J. Chalmers et al.|Clinical and Translational Radiation Oncology|2020Cited by 34